Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Children's Health | Immune System | Arthritis
What is the purpose of this trial?
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
- Ages2 years - 21 years
- Trial withDuke University
- Start Date07/25/2018
- End Date06/30/2028
- Last Updated07/15/2021
- Study HIC#2000023073REG